Close Menu

NEW YORK ─ Seattle-based startup Tasso said on Wednesday that it has closed an oversubscribed $17 million Series A financing round and plans to use the proceeds to scale manufacturing and operations to meet the demand for its push-button blood collection devices.

Tasso OnDemand devices enable people to collect blood without training from the comfort and privacy of the home and mail samples to a CLIA-certified, high-complexity clinical laboratory for testing.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

Amid the COVID-19 pandemic, hospitals and intensive care units around the world have been overwhelmed by unprecedented levels of demand. 

Sponsored by
LGC SeraCare Life Sciences

As we pass the one-year anniversary of both the COVID-19 pandemic and the first Emergency Use Authorized SARS-CoV-2 PCR detection assays, there remains significant opportunity for clinical laboratories to advance testing and support improved patient management.

Sponsored by

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.